Ondavar

Ondavar

ondansetron

Manufacturer:

Darya-Varia
Full Prescribing Info
Contents
Ondansetron.
Description
Each film-coated tablet contains: Ondansetron hydrochloride dihydrate equivalent to Ondansetron 4 mg.
Action
Pharmacology: Ondansetron is a highly selective and competitive 5HT3 receptor antagonist, which inhibits nausea and vomiting caused by cytotoxic agents and radiation.
Indications/Uses
For oral: The management of nausea and vomiting associated with the treatment of cancer by chemotherapy and radiotherapy and for prevention of post-operative nausea and/or vomiting.
Dosage/Direction for Use
For prevention of post-operative nausea vomiting: Initial dose: 8 mg tablet, given 1 hour before anaesthesia, followed by 8 mg tablet every 8 hours for up to 16 hours.
For nausea and vomiting of radiotherapy: 8 mg tablet 8 hourly commencing 1-2 hours prior to the first fraction of radiotherapy. The course of the therapy depend on the duration of radiotherapy.
Elderly: Ondansetron is well tolerated by patients over 65 years and no alteration of dosage, dosing frequency or route of administration are required.
Patients with renal impairment: No alteration of daily dosage or frequency of dosing, or route of administration.
Patients with hepatic impairment: In such patients a total daily dose of 8 mg should not be exceeded.
Overdosage
No specific antidotum.
Contraindications
Ondansetron is contraindicated for patients known to have hypersensitivity to the drug.
Special Precautions
Ondansetron should not be used during pregnancy especially during the first trimester, unless the expected benefit to the patient is thought to outweigh any possible risk to the fetus. Test have shown that Ondansetron is excreted in the breast milk of rats. It is therefore recommended that mothers receiving Ondansetron should not breast feed their babies.
Use In Pregnancy & Lactation
Ondansetron should not be used during pregnancy especially during the first trimester, unless the expected benefit to the patient is thought to outweigh any possible risk to the fetus. Test have shown that Ondansetron is excreted in the breast milk of rats. It is therefore recommended that mothers receiving Ondansetron should not breast feed their babies.
Side Effects
Headache, constipation, hot flushing in the head and epigastria, sedation and diarrhea.
Drug Interactions
No report.
Storage
Store at temperature below 30°C.
MIMS Class
Antiemetics / Supportive Care Therapy
ATC Classification
A04AA01 - ondansetron ; Belongs to the class of serotonin (5HT3) antagonists. Used for the prevention of nausea and vomiting.
Presentation/Packing
Form
Ondavar FC tab 4 mg
Packing/Price
1 × 10's (Rp105,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in